Skip to main content
Log in

RCAN1 Mutation and Functional Characterization in Children with Sporadic Congenital Heart Disease

  • Original Article
  • Published:
Pediatric Cardiology Aims and scope Submit manuscript

Abstract

Congenital heart disease (CHD) is the most frequent birth defect. RCAN1 (regulator of calcineurin 1) contributes to CHD in Down syndrome. However, whether RCAN1 is also associated with nonsyndromic CHD remains unclear. This study sequenced the exons and flanking region of RCAN1 in 128 sporadic CHD patients and 150 normal controls. We identified six novel heterozygous mutations in CHD patients. Functional assay showed that the g.482G>T could obviously raise the promoter activity of RCAN1.4 in vitro; However, we failed to detect the expression of RCAN1 in the right auricle, which made it confused to evaluate the pathogenicity of this mutation. In addition, we demonstrated that c.290T>C and g.1056+58C>A had no effect on the alternative splicing of RCAN1. The *196C>T, *790G>A, and *1278C>G did not influence the translation of RCAN1 post transcription. In conclusion, a novel mutation of g.482G>T in RCAN1 may be related to CHD by causing overexpression of RCAN1.4.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. van der Linde D, Konings EE, Slager MA, Witsenburg M, Helbing WA, Takkenberg JJ, Roos-Hesselink JW (2011) Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol 58:2241–2247

    Article  PubMed  Google Scholar 

  2. Fahed AC, Gelb BD, Seidman JG, Seidman CE (2013) Genetics of congenital heart disease: the glass half empty. Circ Res 112:707–720

    Article  CAS  PubMed  Google Scholar 

  3. Clark KL, Yutzey KE, Benson DW (2006) Transcription factors and congenital heart defects. Annu Rev Physiol 68:97–121

    Article  CAS  PubMed  Google Scholar 

  4. Pierpont ME, Basson CT, Benson DW Jr, Gelb BD, Giglia TM, Goldmuntz E, McGee G, Sable CA, Srivastava D, Webb CL (2007) American Heart Association Congenital Cardiac Defects Committee CoCDitY, Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 115:3015–3038

    Article  PubMed  Google Scholar 

  5. Elmagrpy Z, Rayani A, Shah A, Habas E, Aburawi EH (2011) Down syndrome and congenital heart disease: why the regional difference as observed in the Libyan experience? Cardiovasc J Afr 22:306–309

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Baraona F, Gurvitz M, Landzberg MJ, Opotowsky AR (2013) Hospitalizations and mortality in the United States for adults with Down syndrome and congenital heart disease. Am J Cardiol 111:1046–1051

    Article  PubMed  Google Scholar 

  7. Casas C, Martinez S, Pritchard MA, Fuentes JJ, Nadal M, Guimera J, Arbones M, Florez J, Soriano E, Estivill X, Alcantara S (2001) Dscr1, a novel endogenous inhibitor of calcineurin signaling, is expressed in the primitive ventricle of the heart and during neurogenesis. Mech Dev 101:289–292

    Article  CAS  PubMed  Google Scholar 

  8. Kim SS, Seo SR (2011) The regulator of calcineurin 1 (RCAN1/DSCR1) activates the cAMP response element-binding protein (CREB) pathway. J Biol Chem 286:37841–37848

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Barlow GM, Chen XN, Shi ZY, Lyons GE, Kurnit DM, Celle L, Spinner NB, Zackai E, Pettenati MJ, Van Riper AJ, Vekemans MJ, Mjaatvedt CH, Korenberg JR (2001) Down syndrome congenital heart disease: a narrowed region and a candidate gene. Genet Med 3:91–101

    Article  CAS  PubMed  Google Scholar 

  10. Li X, Wang G, An Y, Li H, Li Y, Wu C (2015) Association between sequence variations in RCAN1 promoter and the risk of sporadic congenital heart disease in a Chinese population. Pediatr Cardiol 36:1393–1399

    Article  PubMed  Google Scholar 

  11. Ogino S, Gulley ML, den Dunnen JT, Wilson RB (2007) Association for Molecular Pathology T, Education C. Standard mutation nomenclature in molecular diagnostics: practical and educational challenges. J Mol Diagn 9:1–6

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Wu Y, Song W (2013) Regulation of RCAN1 translation and its role in oxidative stress-induced apoptosis. FASEB J 27:208–221

    Article  CAS  PubMed  Google Scholar 

  13. Bhoiwala DL, Koleilat I, Qian J, Beyer B, Hushmendy SF, Mathew A, Bhoiwala DL, Ferland RJ, Crawford DR (2013) Overexpression of RCAN1 isoform 4 in mouse neurons leads to a moderate behavioral impairment. Neurol Res 35:79–89

    Article  CAS  PubMed  Google Scholar 

  14. Sun X, Wu Y, Chen B, Zhang Z, Zhou W, Tong Y, Yuan J, Xia K, Gronemeyer H, Flavell RA, Song W (2011) Regulator of calcineurin 1 (RCAN1) facilitates neuronal apoptosis through caspase-3 activation. J Biol Chem 286:9049–9062

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Martin KR, Corlett A, Dubach D, Mustafa T, Coleman HA, Parkington HC, Merson TD, Bourne JA, Porta S, Arbones ML, Finkelstein DI, Pritchard MA (2012) Over-expression of RCAN1 causes Down syndrome-like hippocampal deficits that alter learning and memory. Hum Mol Genet 21:3025–3041

    Article  CAS  PubMed  Google Scholar 

  16. Martin KR, Layton D, Seach N, Corlett A, Barallobre MJ, Arbones ML, Boyd RL, Scott B, Pritchard MA (2013) Upregulation of RCAN1 causes Down syndrome-like immune dysfunction. J Med Genet 50:444–454

    Article  CAS  PubMed  Google Scholar 

  17. Sobrado M, Ramirez BG, Neria F, Lizasoain I, Arbones ML, Minami T, Redondo JM, Moro MA, Cano E (2012) Regulator of calcineurin 1 (Rcan1) has a protective role in brain ischemia/reperfusion injury. J Neuroinflammation 9:48

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Fuentes JJ, Genesca L, Kingsbury TJ, Cunningham KW, Perez-Riba M, Estivill X, de la Luna S (2000) DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways. Hum Mol Genet 9:1681–1690

    Article  CAS  PubMed  Google Scholar 

  19. Ranger AM, Grusby MJ, Hodge MR, Gravallese EM, de la Brousse FC, Hoey T, Mickanin C, Baldwin HS, Glimcher LH (1998) The transcription factor NF-ATc is essential for cardiac valve formation. Nature 392:186–190

    Article  CAS  PubMed  Google Scholar 

  20. de la Pompa JL, Timmerman LA, Takimoto H, Yoshida H, Elia AJ, Samper E, Potter J, Wakeham A, Marengere L, Langille BL, Crabtree GR, Mak TW (1998) Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum. Nature 392:182–186

    Article  PubMed  Google Scholar 

  21. Harris CD, Ermak G, Davies KJA (2005) Multiple roles of the DSCR1 (Adapt78 or RCAN1) gene and its protein product Calcipressin 1 (or RCAN1) in disease. Cell Mol Life Sci 62:2477–2486

    Article  CAS  PubMed  Google Scholar 

  22. Vega RB, Rothermel BA, Weinheimer CJ, Kovacs A, Naseem RH, Bassel-Duby R, Williams RS, Olson EN (2003) Dual roles of modulatory calcineurin-interacting protein 1 in cardiac hypertrophy. Proc Natl Acad Sci USA 100:669–674

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Rothermel B, Vega RB, Yang J, Wu H, Bassel-Duby R, Williams RS (2000) A protein encoded within the Down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling. J Biol Chem 275:8719–8725

    Article  CAS  PubMed  Google Scholar 

  24. Harris CD, Ermak G, Davies KJ (2007) RCAN1-1L is overexpressed in neurons of Alzheimer’s disease patients. FEBS J 274:1715–1724

    Article  CAS  PubMed  Google Scholar 

  25. Lee HJ, Kim YS, Sato Y, Cho YJ (2009) RCAN1-4 knockdown attenuates cell growth through the inhibition of Ras signaling. FEBS Lett 583:2557–2564

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors feel grateful to the children and parents involved in the study. This research was funded by Grant WX15A11 from Wuhan Municipal Planning Commission of Science and Research Fund. We would like to thank the great assistance from Dr. Chun Wu (Children’s Hospital of Chongqing Medical University).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jing Jin.

Ethics declarations

Conflict of interest

None.

Ethical Approval

All authors state that this study complies with the Declaration of Helsinki.

Informed Consent

Informed consent was obtained from all individual participants included in the study (written consent from parents and written assent from children).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, X., Shi, L., Xu, M. et al. RCAN1 Mutation and Functional Characterization in Children with Sporadic Congenital Heart Disease. Pediatr Cardiol 39, 226–235 (2018). https://doi.org/10.1007/s00246-017-1746-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00246-017-1746-y

Keywords

Navigation